On January 6, Zacks Investment Research highlighted three stocks with strong momentum and a buy rank. NRx Pharmaceuticals, Inc. (NRXP) experienced a 46.2% increase in its current year earnings estimate over the last 60 days and its shares surged by 79.3% in the past three months. The company holds a Zacks Rank of #1 and a Momentum Score of A.
Pro-Dex, Inc. (PDEX) also has a Zacks Rank of #1, with a 40.9% increase in its earnings estimate and a 67.7% rise in shares over the same three-month period. Meanwhile, Puma Biotechnology, Inc. (PBYI) reported a 24% increase in its earnings estimate, along with a share price increase of 10.9%, maintaining a Zacks Rank of #1 and a Momentum Score of A.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
